Is BPC-157 FDA-approved?
The short answer is no for consumer longevity or injury claims; verify any product-specific claim against official FDA records.
Source type: Fda
Author: LHN Evidence Desk
Topic: peptides
Human review: Required before production publication
Direct answer
No. BPC-157 should be treated as unapproved for longevity, recovery or injury-healing claims unless a current official FDA record says otherwise for a specific product and use.
What the source says
- FDA approval is product- and indication-specific, not a general endorsement of a molecule name.
- Compounded or research-market availability is not the same thing as FDA approval.
- Official FDA pages are the right place to verify regulatory status before publication.
What it does not prove
- It does not prove BPC-157 improves injuries in humans.
- It does not establish product identity, sterility or quality.
- It does not make social-media recovery stories reliable evidence.
Practical takeaway
Separate the regulatory question from the biology question: the regulatory answer is the first gate, and for BPC-157 it is not an approved longevity or injury product.
Ask a qualified clinician if
you are considering any peptide-related claim, have an existing condition, take prescription medication or are being offered a compounded product.
What to watch next
- FDA compounding updates and advisory committee materials.
- Registered human trials with transparent endpoints.
- Quality-control disclosures from any clinical or commercial claim.
FAQs
Can a compounded BPC-157 product be called FDA-approved?
No. Compounded drugs are not FDA-approved products, even when prepared by licensed professionals.
Does this mean all peptide research is worthless?
No. It means the claim needs to be matched to the evidence level and regulatory status.
Source links
- Bulk drug substances used in compounding under section 503A — FDA
Primary place to verify FDA compounding context.
- PubMed — NIH / NLM
Primary literature search starting point.
Related articles
Does BPC-157 heal injuries in humans?
BPC-157 has animal and mechanism-heavy discussion, but that is not the same as strong human injury evidence.
Are compounded peptides FDA-approved?
Compounding can be lawful in some circumstances, but compounded drugs themselves are not FDA-approved products.